 | • レポートコード：MRC2303N112 • 出版社/出版日：Mordor Intelligence / 2023年1月23日 • レポート形態：英文、PDF、154ページ • 納品方法：Eメール（受注後2-3営業日） • 産業分類：包装 |
| Single User | ￥712,500 (USD4,750) | ▷ お問い合わせ |
| Corporate License | ￥1,312,500 (USD8,750) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| モルドールインテリジェンス社では、2021年に80.8億ドルであった世界の医薬品用ペットボトル市場規模が、2022年から2027年にかけて年平均成長率4.11%を記録し、2027年には103.9億ドルに達すると予測しています。本調査レポートでは、医薬品用ペットボトルの世界市場について総合的に調査・分析し、イントロダクション、調査手法、エグゼクティブサマリー、市場インサイト、市場動向、原材料別（ポリエチレンテレフタレート(PET)、ポリプロピレン(PP)、低密度ポリエチレン(LDPE)、高密度ポリエチレン(HDPE)）分析、種類別（固形容器、スポイトボトル、点鼻スプレーボトル、液体ボトル、その他）分析、地域別（アメリカ、カナダ、イギリス、ドイツ、フランス、中国、インド、日本、ブラジル、アルゼンチン、メキシコ、サウジアラビア、UAE、南アフリカ）分析、競争状況、投資分析、市場機会・将来の動向などの内容でまとめております。なお、当書に掲載されている企業情報には、Amcor Limited、Gerresheimer AG、Berry Group Inc.、Aptar Pharma、O.Berk Company LLC、Alpha Packaging、Pro-Pac Packaging Ltd、COMAR LLC、Gil Plastic Products Ltd、Drug Plastics Group、Frapak Packagingなどが含まれています。 ・イントロダクション ・調査手法 ・エグゼクティブサマリー ・市場インサイト ・市場動向 ・世界の医薬品用ペットボトル市場規模：原材料別 - ポリエチレンテレフタレート(PET)の市場規模 - ポリプロピレン(PP)の市場規模 - 低密度ポリエチレン(LDPE)の市場規模 - 高密度ポリエチレン(HDPE)の市場規模 ・世界の医薬品用ペットボトル市場規模：種類別 - 固形容器の市場規模 - スポイトボトルの市場規模 - 点鼻スプレーボトルの市場規模 - 液体ボトルの市場規模 - その他種類の市場規模 ・世界の医薬品用ペットボトル市場規模：地域別 - 北米の医薬品用ペットボトル市場規模 アメリカの医薬品用ペットボトル市場規模 カナダの医薬品用ペットボトル市場規模 … - ヨーロッパの医薬品用ペットボトル市場規模 イギリスの医薬品用ペットボトル市場規模 ドイツの医薬品用ペットボトル市場規模 フランスの医薬品用ペットボトル市場規模 … - アジア太平洋の医薬品用ペットボトル市場規模 中国の医薬品用ペットボトル市場規模 インドの医薬品用ペットボトル市場規模 日本の医薬品用ペットボトル市場規模 … - 中南米の医薬品用ペットボトル市場規模 ブラジルの医薬品用ペットボトル市場規模 アルゼンチンの医薬品用ペットボトル市場規模 メキシコの医薬品用ペットボトル市場規模 … - 中東・アフリカの医薬品用ペットボトル市場規模 サウジアラビアの医薬品用ペットボトル市場規模 UAEの医薬品用ペットボトル市場規模 南アフリカの医薬品用ペットボトル市場規模 … - その他地域の医薬品用ペットボトル市場規模 ・競争状況 ・投資分析 ・市場機会・将来の動向 |
The pharmaceutical plastic bottles market was valued at USD 8.08 billion in 2021 and is expected to reach USD 10.39 billion by 2027, registering a CAGR of 4.11% during 2022-2027. The growing demand for the packaging in pharmaceuticals for the storage and delivery of medicines is expected to drive the market during the forecast period.
Key Highlights
- The demand for plastic packaging has witnessed significant growth in the pharmaceutical industry because of its unmatched ability. Additional features that led to increased adoption in pharma are barrier against moisture, high dimensional stability, high impact strength, resistance to strain, low water absorption, transparency, resistance to heat and flame, and extension of expiry dates.
- The market for pharmaceutical plastic bottles is growing due to growing sustainability concerns by increasing the recycling rate and minimizing the environmental impact in the pharmaceutical industry. Technological advancement and the rising application of plastic bottles in solid and even liquid oral medicines have added to market growth for pharmaceutical plastic bottles. However, the rise in the price of plastics due to fluctuating prices of crude oil and various regulations would reflect on the increase in the price of plastics, which may affect the consumption of the product and further hinder the growth of the market studied.
- Plastic bottles are increasingly used for aseptic filling and packaging in the industry. Market vendors provide aseptic bottle filling and packaging services in various regions. For instance, LSNE offers aseptic dropper bottle filling services. The company has an automated filling line capable of filling standard multi-dose three-piece bottles in 5 ml and 10 ml bottles and sterile multi-dose bottles.
- Asia-Pacific has a prominent base for the production of PET resin and polymers, which is also aiding the growth of the market with no issues of a supply shortage of raw material. China is one of the largest producing and consuming countries of PET bottles.
- With the increasing demand for medicine and other essential goods at an all-time high, a lack of available packaging to package and ship them further caused a significant interruption in supply chains. However, the demand increased for some medicines used in patients with COVID-19. These included some anesthetics, antibiotics, muscle relaxants, and some off-label medicines. This led to the supply of plastic bottles in the pharmaceutical companies.
Pharmaceutical Plastic Bottles Market Trends
HDPE Segment to Report the Highest Growth Rate
- HDPE is used to manufacture various types of bottles, and among those, un-pigmented bottles are translucent, with excellent stiffness and barrier properties. The material has a pigmented variety, which can package light-sensitive drugs in the pharmaceutical industry. These materials are suited for packaging products with a short shelf life. According to American Chemical Council, in 2021, the United States produced 123.9 billion pounds of resins, in which thermoplastics accounted for roughly 86% of total production. High-density polyethylene (HDPE) was the most produced resin that year, with an output of 22 billion pounds.
- HDPE also has excellent chemical resistance, which presents it as a valuable material for packaging various chemicals and medicinal products. Pigmented HDPE bottles are witnessed to have improved stress crack resistance than un-pigmented HDPE material. The blow-molding application of HDPE makes it more durable and more versatile than PP and LDPE materials. It also has excellent resistance to most solvents and high tensile strength compared to other forms of polyethylene materials.
- HDPE is also primarily used for larger containers in the commercial sector as it has a high strength-to-weight ratio in common polymers and is less brittle than PP. It maintains a lightweight nature in molding, making it suitable for larger containers, like plastic canisters.
- Further, there have been various research and development activities by multiple players in the market. For instance, in April 2021, Advil maker GSK Consumer Healthcare (GSK) announced a commitment to reducing the plastic in more than 80 million Advil bottles by 20%, which will result in a reduction of nearly 500,000 pounds of plastic in the environment. By 2022, Advil is expected to reduce plastic in nearly all bottles available in stores and online, except the brand’s Easy Open bottles. The new barrier resin technology reduces the amount of resin required to mold and craft the high-density polyethylene (HDPE) bottles while maintaining barrier protection properties.
North America Accounts for a Significant Market Share
- The US plastic bottles market is estimated to grow at a steady rate, owing to the constantly increasing consumption and industrial applications of plastic-made containers and bottles. According to the Plastics Industry Association (PLASTICS), the market demand for plastic bottles continues to expand in the United States.
- According to Pharmaceutical Commerce, in the United States, the pharmaceutical market is on the rise. By 2023, it is expected that Americans would spend USD 635 to USD 655 billion on pharmaceuticals. As a result, the United States will be the country with the greatest pharmaceutical spending.
- Moreover, according to Pharmaceutical Commerce, in the United States, the pharmaceutical market is on the rise. By 2023, it is expected that Americans will spend USD 635 to USD 655 billion on pharmaceuticals. As a result, it will almost certainly be the country with the most significant pharmaceutical spending.
- The plastic resin and products sector employs 93,000 people across 1,932 establishments. With usage in almost every modern product, plastic products are in demand in Canada in most sectors of the economy, with three categories packaging, construction, and automotive accounting for 69% of plastic end use.
Pharmaceutical Plastic Bottles Market Competitor Analysis
The pharmaceutical plastic bottle market is fragmented with the presence of many players like Amcor Limited. Berry Plastics Group, Inc., Aptar Pharma, Gerresheimer AG, Graham Packaging Company, Alpha Packaging, and Alpack Plastic Packaging. The players have adopted various organic and inorganic strategies such as mergers & acquisitions, partnerships, new product launches, and collaborations to dominate the market.
- December 2021 – Comar announced that it acquired Omega Packaging, an injection, and blow-molded product manufacturer. Omega Packaging’s line of child-resistant (CR) closures and precision mold-building capabilities advance Comar’s strategy to serve healthcare customers with end-to-end custom manufacturing capabilities and an expanded product portfolio.
- September 2021 – Clearlake Capital Group portfolio company Pretium Packaging agreed to acquire US-based Alpha Packaging from Irving Place Capital for an undisclosed sum. Alpha Packaging and Pretium Packaging will allow the combined entity to offer a wide range of advanced packaging solutions to both firms’ existing customer bases and new customers.
Additional Benefits:
- The market estimate (ME) sheet in Excel format
- 3 months of analyst support
1 INTRODUCTION
1.1 Study Assumptions and Market Definition
1.2 Scope of the Study
2 RESEARCH METHODOLOGY
3 EXECUTIVE SUMMARY
4 MARKET INSIGHTS
4.1 Market Overview
4.2 Industry Attractiveness – Porter’s Five Forces Analysis
4.2.1 Threat of New Entrants
4.2.2 Bargaining Power of Buyer
4.2.3 Bargaining Power of Suppliers
4.2.4 Threat of Substitute Products
4.2.5 Intensity of Competitive Rivalry
4.3 Industry Value Chain Analysis
4.4 Assessment of the Impact of COVID-19 on the Market
5 MARKET DYNAMICS
5.1 Market Drivers
5.1.1 Growing Need for Lightweight Pharma Bottles by Consumers
5.1.2 Increasing Spending on Healthcare and Pharmaceutical to Augment the Market Growth
5.2 Market Restraints
5.2.1 Increasing Raw Material Costs
5.2.2 Environmental Concerns over Usage of Plastics
6 MARKET SEGMENTATION
6.1 By Raw Material
6.1.1 Polyethylene Terephthalate (PET)
6.1.2 Poly Propylene (PP)
6.1.3 Low-density Poly Ethylene (LDPE)
6.1.4 High-density Poly Ethylene (HDPE)
6.2 By Type
6.2.1 Solid Containers
6.2.2 Dropper Bottles
6.2.3 Nasal Spray Bottles
6.2.4 Liquid Bottles
6.2.5 Oral Care
6.2.6 Other Types
6.3 By Geography
6.3.1 North America
6.3.1.1 United States
6.3.1.2 Canada
6.3.2 Europe
6.3.2.1 United Kingdom
6.3.2.2 Germany
6.3.2.3 France
6.3.2.4 Rest of Europe
6.3.3 Asia-Pacific
6.3.3.1 China
6.3.3.2 India
6.3.3.3 Japan
6.3.3.4 Rest of Asia-Pacific
6.3.4 Latin America
6.3.4.1 Brazil
6.3.4.2 Argentina
6.3.4.3 Mexico
6.3.4.4 Rest of Latin America
6.3.5 Middle East & Africa
6.3.5.1 Saudi Arabia
6.3.5.2 United Arab Emirates
6.3.5.3 South Africa
6.3.5.4 Rest of Middle East & Africa
7 COMPETITIVE LANDSCAPE
7.1 Company Profiles*
7.1.1 Amcor Limited
7.1.2 Gerresheimer AG
7.1.3 Berry Group Inc.
7.1.4 Aptar Pharma
7.1.5 O.Berk Company LLC
7.1.6 Alpha Packaging
7.1.7 Pro-Pac Packaging Ltd
7.1.8 COMAR LLC
7.1.9 Gil Plastic Products Ltd
7.1.10 Drug Plastics Group
7.1.11 Frapak Packaging
8 INVESTMENT ANALYSIS
9 MARKET OPPORTUNITIES AND FUTURE TRENDS